Daniel Tomaszewski, PharmD, Discusses How Practices in Managed Care Pharmacy Guided Legislation
Daniel Tomaszewski, PharmD, PhD Candidate, an assistant professor at the University of Minnesota, College of Pharmacy, Duluth, discusses the impact of managed care pharmacy on current legislation, regulatory policies, and ongoing healthcare reform.
This video was taken at the Academy of Managed Care Pharmacy's 25th Annual Meeting & Expo in San Diego, CA, on April 4, 2013.
Putting various branded drugs in “non-preferred” tiers and charging higher copays for them has been used for a number of years to steer consumers to use less costly medicines by giving them “skin in the game.” But authors writing for The American Journal of Managed Care are alarmed by the policies of some insurers that now have designated entire classes of widely used generic drugs “non-preferred,” leaving many patients without any low-cost treatment options for their diseases.
A study published today found that 16 major U.S. food companies that pledged to cut calories from foods sold consumers cut 6.4 million calories, or 10.6 percent, over a five-year period ending in 2012. Authors of the study say the results show that selling Americans healthier food need not be at odds with a healthy bottom line, and that “the results should encourage other manufacturers and retailers to follow suit.”
A study published in the Annals of Internal Medicine, the result of a collaboration between CVS Caremark and scientists at the Brigham and Women's Hospital and the Harvard Medical School, compared patient adherence to brand name versus generic statins.